Table 1.
Correlation of SMARCE1 expression with the clinicopathological characteristics of GC patients
| Variables | n | SMARCE1 expression | P-value | |
|---|---|---|---|---|
| High (n=77) | Low (n=45) | |||
| Gender | 0.124 | |||
| Male | 81 | 55 | 26 | |
| Female | 41 | 22 | 19 | |
| Age, years | 0.735 | |||
| ≤60 | 43 | 28 | 15 | |
| >60 | 79 | 49 | 30 | |
| Tumor size, cm | 0.017 | |||
| ≤5 | 56 | 29 | 27 | |
| >5 | 66 | 48 | 18 | |
| Depth of invasion | 0.006 | |||
| T1+T2 | 51 | 25 | 26 | |
| T3+T4 | 71 | 52 | 19 | |
| Differentiation | 0.022 | |||
| Well or moderate | 54 | 28 | 26 | |
| Poor or other | 68 | 49 | 19 | |
| Lymph node involvement | 0.020 | |||
| Absence | 46 | 23 | 23 | |
| Presence | 76 | 54 | 22 | |
| Distant metastasis | 0.970 | |||
| Absence | 114 | 72 | 42 | |
| Presence | 8 | 5 | 3 | |
| TNM stage | 0.005 | |||
| I–II | 53 | 26 | 27 | |
| III–IV | 69 | 51 | 18 | |
Note: Bold values are statistically significant p<0.05.
Abbreviation: GC, gastric cancer.